Blueprint Medicines Corporation (BPMC) - Stock Analysis

Get a real-time Blueprint Medicines Corporation (BPMC) stock price quote with breaking news, financials, statistics, charts and more. ... Blueprint Medicines Corporation (NASDAQ:BPMC) …

CouponFollow Extension

$128
OFF

Key Takeaways From Blueprint Medicines Analyst Ratings

1 week from now

2 days ago · Blueprint Medicines (NASDAQ:BPMC) ... analysts have established 12-month price targets, indicating an average target of $128.0, along with a high estimate of $151.00 and a …

nasdaq.com

13%
OFF

Blueprint Medicines Stock Forecast - Stock Analysis

1 week from now

Nov 6, 2024 · Stock Analysis Pro. Watchlist. Collapse. Blueprint Medicines Corporation (BPMC) NASDAQ: BPMC · Real-Time Price · USD. Watchlist Compare. 99.63 +2.08 (2.13%) Nov 6, …

stockanalysis.com

6%
OFF

Blueprint Medicines - BPMC - Stock Price & News | The Motley Fool

1 week from now

Real time Blueprint Medicines (BPMC) stock price quote, stock graph, ... Blueprint Medicines (NASDAQ: BPMC) $100.83 (-0.6%) ... News & Analysis.

fool.com

$122.11
OFF

Blueprint Medicines (BPMC) Stock Forecast & Price Target

1 week from now

3 days ago · According to the 21 analysts' twelve-month price targets for Blueprint Medicines, the average price target is $122.11. The highest price target for BPMC is $168.00, while the …

marketbeat.com

$100.83
OFF

Blueprint Medicines (NASDAQ:BPMC) Stock Quotes, Forecast And …

1 week from now

Nov 8, 2024 · What is the current price for Blueprint Medicines (BPMC)? A The stock price for Blueprint Medicines (NASDAQ: BPMC) is $100.83 last updated November 8, 2024 at 4:00 PM …

benzinga.com

$83.40
OFF

Needham & Company LLC Reaffirms Buy Rating For Blueprint …

1 week from now

Oct 30, 2024 · Get Our Latest Stock Analysis on Blueprint Medicines Blueprint Medicines Stock Up 0.8 %. BPMC opened at $83.40 on Wednesday. Blueprint Medicines has a fifty-two week …

marketbeat.com

$61.10
OFF

JPMorgan Chase & Co. Initiates Coverage On Blueprint Medicines …

1 week from now

3 days ago · Blueprint Medicines has a 12-month low of $61.10 and a 12-month high of $121.90. The firm has a market capitalization of $6.15 billion, a P/E ratio of -45.91 and a beta of 0.59. …

marketbeat.com

$2
OFF

Blueprint Medicines Stock Underpriced With $2bn+ Peak Sales In …

1 week from now

3 days ago · On Thursday, JPMorgan (NYSE: JPM) initiated coverage on Blueprint Medicines (NASDAQ: BPMC) stock with an Overweight rating and set a price target of $126.00. The firm …

investing.com

$6.96
OFF

Blueprint Medicines (NASDAQ:BPMC) Given Buy Rating At

1 week from now

2 days ago · Read Our Latest Analysis on Blueprint Medicines. Blueprint Medicines Stock Performance. Shares of NASDAQ:BPMC traded down $6.96 on Friday, hitting $88.69. …

marketbeat.com

21%
OFF

Blueprint Medicines Co. (NASDAQ:BPMC) Shares Sold By Prime …

1 week from now

17 minutes ago · Insiders own 4.21% of the company's stock. Blueprint Medicines Price Performance. Shares of BPMC opened at $88.69 on Friday. The company has a debt-to …

marketbeat.com

$61.10
OFF

10,800 Shares In Blueprint Medicines Co. (NASDAQ:BPMC

1 week from now

3 days ago · Blueprint Medicines Co. has a 12-month low of $61.10 and a 12-month high of $121.90. The stock has a market capitalization of $6.15 billion, a PE ratio of -45.91 and a beta …

marketbeat.com

$62.56
OFF

Entropy Technologies LP Buys New Shares In Blueprint Medicines …

1 week from now

3 days ago · Blueprint Medicines Co. has a twelve month low of $62.56 and a twelve month high of $121.90. The company has a debt-to-equity ratio of 1.09, a current ratio of 3.32 and a quick …

marketbeat.com

FAQs about Blueprint Medicines Corporation (BPMC) - Stock Analysis Coupon?

What is BPMC blueprint medicines Corporation stock price?

Search for Symbols, analysts, keywords Log in BPMC Blueprint Medicines Corporation Stock Price & Overview Follow $86.470.86(+1.00%)4:00 PM 10/22/24 NASDAQ |$USD |Post-Market:$86.475:33 PM ...

Is blueprint medicines a good stock to buy?

Blueprint Medicines has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 7 buy ratings, 7 hold ratings, and 1 sell rating. According to analysts' consensus price target of $72.68, Blueprint Medicines has a forecasted upside of 66.7% from its current price of $43.61. ...

Does NASDAQ use the BPMC stock value to determine compliance?

NASDAQ does not use this value to determine compliance with the listing requirements. Blueprint Medicines Corporation Common Stock (BPMC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. ...

Who is blueprint medicines Corp?

Learn More Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA. ...

How much does blueprint medicines make?

Blueprint Medicines (NASDAQ:BPMC) has a market capitalization of $2.64 billion and generates $204.04 million in revenue each year. The biotechnology company earns $-557,520,000.00 in net income (profit) each year or ($9.35) on an earnings per share basis. ...

What does BPMC stand for?

LOS ANGELES, CA / ACCESSWIRE / August 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medic... Get a real-time Blueprint Medicines Corporation (BPMC) stock price quote with breaking news, financials, statistics, charts and more. ...